China National Accord Medicines Corp Ltd (200028) — Financial Flexibility Index
China National Accord Medicines Corp Ltd (200028) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of HK$-364.00 Million (operating CF HK$-424.00 Million minus capex HK$60.00 Million) represents 0% of total liabilities (HK$29.01 Billion). Also explore 200028 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China National Accord Medicines Corp Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for China National Accord Medicines Corp Ltd across 28 annual periods. Check China National Accord Medicines Corp Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for China National Accord Medicines Corp Ltd. For the full company profile including market capitalisation, see market value of China National Accord Medicines Corp Ltd.
| Year | Flexibility Index | Free Cash Flow (HKD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | HK$1.86 Billion | HK$1.64 Billion | HK$27.47 Billion | ▼ -49.1% |
| 2024 | 0.13x | HK$3.55 Billion | HK$3.27 Billion | HK$26.80 Billion | ▲ +8.2% |
| 2023 | 0.12x | HK$3.26 Billion | HK$2.94 Billion | HK$26.59 Billion | ▼ -1.5% |
| 2022 | 0.12x | HK$2.88 Billion | HK$2.56 Billion | HK$23.17 Billion | ▲ +52.1% |
| 2021 | 0.08x | HK$2.03 Billion | HK$1.66 Billion | HK$24.76 Billion | ▲ +3.4% |
| 2020 | 0.08x | HK$1.80 Billion | HK$1.50 Billion | HK$22.71 Billion | ▼ -36.0% |
| 2019 | 0.12x | HK$2.25 Billion | HK$2.00 Billion | HK$18.16 Billion | ▲ +17.7% |
| 2018 | 0.11x | HK$1.58 Billion | HK$1.32 Billion | HK$15.02 Billion | ▼ -12.5% |
| 2017 | 0.12x | HK$1.49 Billion | HK$1.29 Billion | HK$12.42 Billion | ▼ -14.4% |
| 2016 | 0.14x | HK$1.74 Billion | HK$1.47 Billion | HK$12.40 Billion | ▼ -13.4% |
| 2015 | 0.16x | HK$1.24 Billion | HK$1.05 Billion | HK$7.65 Billion | ▲ +384.4% |
| 2014 | -0.06x | HK$-454.03 Million | HK$-796.70 Million | HK$7.98 Billion | ▼ -180.8% |
| 2013 | 0.07x | HK$615.52 Million | HK$465.03 Million | HK$8.74 Billion | ▲ +1.5% |
| 2012 | 0.07x | HK$517.53 Million | HK$323.96 Million | HK$7.46 Billion | ▲ +1.6% |
| 2011 | 0.07x | HK$426.29 Million | HK$227.32 Million | HK$6.24 Billion | ▼ -41.7% |
| 2010 | 0.12x | HK$606.15 Million | HK$428.16 Million | HK$5.18 Billion | ▲ +36.5% |
| 2009 | 0.09x | HK$373.78 Million | HK$270.85 Million | HK$4.36 Billion | ▼ -21.5% |
| 2008 | 0.11x | HK$331.56 Million | HK$246.58 Million | HK$3.03 Billion | ▲ +64.0% |
| 2007 | 0.07x | HK$159.11 Million | HK$87.70 Million | HK$2.39 Billion | ▼ -51.0% |
| 2006 | 0.14x | HK$299.95 Million | HK$181.73 Million | HK$2.21 Billion | ▼ -53.6% |
| 2005 | 0.29x | HK$198.90 Million | HK$148.28 Million | HK$678.73 Million | ▼ -1.0% |
| 2004 | 0.30x | HK$144.48 Million | HK$130.30 Million | HK$487.99 Million | ▲ +50.9% |
| 2003 | 0.20x | HK$130.58 Million | HK$81.22 Million | HK$665.47 Million | ▲ +153.1% |
| 2002 | 0.08x | HK$55.66 Million | HK$28.76 Million | HK$717.90 Million | ▼ -45.4% |
| 2001 | 0.14x | HK$107.06 Million | HK$71.16 Million | HK$753.72 Million | ▼ -58.7% |
| 2000 | 0.34x | HK$29.53 Million | HK$8.52 Million | HK$85.83 Million | ▼ -40.8% |
| 1999 | 0.58x | HK$50.38 Million | HK$22.84 Million | HK$86.72 Million | ▲ +325.2% |
| 1998 | 0.14x | HK$15.59 Million | HK$5.21 Million | HK$114.11 Million | — |